Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Verrica Pharmaceuticals Inc (NQ: VRCA ) 0.9700 +0.1400 (+16.87%) Streaming Delayed Price Updated: 3:36 PM EST, Nov 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Verrica Pharmaceuticals Inc < Previous 1 2 3 4 5 6 7 8 Next > VERRICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Verrica Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm May 17, 2024 From Bragar Eagel & Squire Via GlobeNewswire Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts May 15, 2024 From Verrica Pharmaceuticals Inc. Via GlobeNewswire Planet Fitness To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday May 14, 2024 Via Benzinga Earnings Scheduled For February 29, 2024 February 29, 2024 Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. Via Benzinga Earnings Outlook For Verrica Pharmaceuticals February 28, 2024 Via Benzinga VRCA Stock Earnings: Verrica Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 May 13, 2024 VRCA stock results show that Verrica Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results May 13, 2024 From Verrica Pharmaceuticals Inc. Via GlobeNewswire Verrica Pharmaceuticals to Present at Upcoming Investor Conferences May 09, 2024 From Verrica Pharmaceuticals Inc. Via GlobeNewswire Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024 May 08, 2024 From Verrica Pharmaceuticals Inc. Via GlobeNewswire Bragar Eagel & Squire is Investigating Certain Officers and Directors of Caribou, Verrica, and Playstudios on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm April 27, 2024 From Bragar Eagel & Squire Via GlobeNewswire Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference April 02, 2024 From Verrica Pharmaceuticals Inc. Via GlobeNewswire Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA March 26, 2024 From Verrica Pharmaceuticals Inc. Via GlobeNewswire VERRICA PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA March 08, 2024 From Kahn Swick & Foti, LLC Via Business Wire Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results February 29, 2024 From Verrica Pharmaceuticals Inc. Via GlobeNewswire Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference February 27, 2024 From Verrica Pharmaceuticals Inc. Via GlobeNewswire Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 Financial Results on February 29, 2024 February 22, 2024 From Verrica Pharmaceuticals Inc. Via GlobeNewswire VERRICA PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA February 14, 2024 From Kahn Swick & Foti, LLC Via Business Wire Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising and Unfair Competition February 05, 2024 From Verrica Pharmaceuticals Inc. Via GlobeNewswire Verrica Pharmaceuticals Receives Permanent J-Code (J7354) for YCANTH™ from Centers for Medicare and Medicaid Services January 29, 2024 From Verrica Pharmaceuticals Inc. Via GlobeNewswire 7 Potential Short-Squeeze Stocks Poised for Rapid Gains January 22, 2024 Giving the bears a rough time can yield massive gains for contrarians, thus drawing attention to these potential short-squeeze stocks. Via InvestorPlace Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma January 05, 2024 From Verrica Pharmaceuticals Inc. Via GlobeNewswire Verrica Pharmaceuticals Announces Receipt of Minutes from Type C Meeting with FDA Regarding Clinical Development of YCANTH™ for the Treatment of Common Warts January 04, 2024 From Verrica Pharmaceuticals Inc. Via GlobeNewswire Verrica Pharmaceuticals Announces Specialty Pharmacy Partnership Agreement with Walgreens to Distribute YCANTH™ January 03, 2024 From Verrica Pharmaceuticals Inc. Via GlobeNewswire Top 4 Health Care Stocks That May Crash This Month December 20, 2023 As of Dec. 20, 2023, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. Via Benzinga Insiders Buying Pfizer And 3 Other Stocks December 20, 2023 Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades. Via Benzinga Why Is Verrica Pharmaceuticals (VRCA) Stock Up 40% Today? December 15, 2023 With Verrica Pharmaceuticals releasing positive Phase 3 trial results for a skin disease therapeutic, VRCA stock skyrocketed in response. Via InvestorPlace Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) Near the Top of Equities by Percentage Gain on 12/15 December 15, 2023 Via Investor Brand Network Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 15, 2023 Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session December 15, 2023 Via Benzinga Why Is Skin Disease-Focused Verrica Pharmaceuticals Stock Trading Higher Today? December 15, 2023 Verrica Pharmaceuticals Inc's (NASDAQ: VRCA) development and commercialization partner, Torii Pharmaceutical Co Ltd, reported topline results from its Phase 3 trial of TO-208 (referred to as VP-102 and... Via Benzinga < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
